A R M Coates

Summary

Affiliation: St George's
Country: UK

Publications

  1. ncbi The unusual chaperonins of Mycobacterium tuberculosis
    Rohini Qamra
    Centre for DNA Fingerprinting and Diagnostics, ECIL Road, Nacharam, Hyderabad 500 076, India
    Tuberculosis (Edinb) 85:385-94. 2005
  2. ncbi New strategies for antibacterial drug design: targeting non-multiplying latent bacteria
    Anthony R M Coates
    Department of Cellular and Molecular Medicine, Medical Microbiology, Centre for Infection, St George s University of London, London, UK
    Drugs R D 7:133-51. 2006
  3. ncbi Stress wars: the direct role of host and bacterial molecular chaperones in bacterial infection
    Brian Henderson
    Division of Microbial Diseases, UCL Eastman Dental Institute, University College London, 256 Gray's Inn Road, London WC1X, United Kingdom
    Infect Immun 74:3693-706. 2006
  4. ncbi Novel classes of antibiotics or more of the same?
    Anthony R M Coates
    Medical Microbiology, Centre for Infection, Department of Clinical Sciences, St George s, University of London, UK
    Br J Pharmacol 163:184-94. 2011
  5. ncbi Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects
    T Coates
    University College London, London, UK
    J Antimicrob Chemother 64:9-15. 2009
  6. ncbi Targeting non-multiplying organisms as a way to develop novel antimicrobials
    Anthony R M Coates
    Medical Microbiology, Centre for Infection, Department of Cellular and Molecular Medicine, St George s, University of London, Cranmer Terrace, London, UK
    Trends Pharmacol Sci 29:143-50. 2008
  7. ncbi Novel approaches to developing new antibiotics for bacterial infections
    A R M Coates
    Medical Microbiology, Department of Cellular and Molecular Medicine, St George s, University of London, London, UK
    Br J Pharmacol 152:1147-54. 2007
  8. ncbi Differential regulation of circulating levels of molecular chaperones in patients undergoing treatment for periodontal disease
    Alireza Shamaei-Tousi
    Division of Microbial Diseases, UCL Eastman Dental Institute, University College London, London, United Kingdom
    PLoS ONE 2:e1198. 2007
  9. ncbi Comparison of the sterilising activities of the nitroimidazopyran PA-824 and moxifloxacin against persisting Mycobacterium tuberculosis
    Y Hu
    Medical Microbiology, Department of Cellular and Molecular Medicine, St George s Hospital, University of London, London, United Kingdom
    Int J Tuberc Lung Dis 12:69-73. 2008
  10. ncbi Caught with their PAMPs down? The extracellular signalling actions of molecular chaperones are not due to microbial contaminants
    Brian Henderson
    UCL Eastman Dental Institute, University College London, UK
    Cell Stress Chaperones 15:123-41. 2010

Collaborators

Detail Information

Publications11

  1. ncbi The unusual chaperonins of Mycobacterium tuberculosis
    Rohini Qamra
    Centre for DNA Fingerprinting and Diagnostics, ECIL Road, Nacharam, Hyderabad 500 076, India
    Tuberculosis (Edinb) 85:385-94. 2005
    ..Recent work has shown intriguing structural, biochemical and signaling properties of the M. tuberculosis chaperonins. This review details the recent developments in the study of the M. tuberculosis chaperonins...
  2. ncbi New strategies for antibacterial drug design: targeting non-multiplying latent bacteria
    Anthony R M Coates
    Department of Cellular and Molecular Medicine, Medical Microbiology, Centre for Infection, St George s University of London, London, UK
    Drugs R D 7:133-51. 2006
    ..The genomic approach has been disappointing so far, but it is still hoped that this will produce novel antibacterial agents...
  3. ncbi Stress wars: the direct role of host and bacterial molecular chaperones in bacterial infection
    Brian Henderson
    Division of Microbial Diseases, UCL Eastman Dental Institute, University College London, 256 Gray's Inn Road, London WC1X, United Kingdom
    Infect Immun 74:3693-706. 2006
  4. ncbi Novel classes of antibiotics or more of the same?
    Anthony R M Coates
    Medical Microbiology, Centre for Infection, Department of Clinical Sciences, St George s, University of London, UK
    Br J Pharmacol 163:184-94. 2011
    ..Industry needs to re-enter the market on a much larger scale, and academia should rebuild its antibiotic discovery infrastructure to support this effort. The alternative is Medicine without effective antibiotics...
  5. ncbi Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects
    T Coates
    University College London, London, UK
    J Antimicrob Chemother 64:9-15. 2009
    ..Furthermore, a more bactericidal antibiotic than mupirocin is needed, on the grounds that it might reduce the relapse rate, and so clear the patient of MRSA for a longer period of time than mupirocin...
  6. ncbi Targeting non-multiplying organisms as a way to develop novel antimicrobials
    Anthony R M Coates
    Medical Microbiology, Centre for Infection, Department of Cellular and Molecular Medicine, St George s, University of London, Cranmer Terrace, London, UK
    Trends Pharmacol Sci 29:143-50. 2008
    ..Lastly, we review the potential of new molecular targets and live non-multiplying bacteria as possible routes for the development of novel antimicrobial drugs...
  7. ncbi Novel approaches to developing new antibiotics for bacterial infections
    A R M Coates
    Medical Microbiology, Department of Cellular and Molecular Medicine, St George s, University of London, London, UK
    Br J Pharmacol 152:1147-54. 2007
    ....
  8. ncbi Differential regulation of circulating levels of molecular chaperones in patients undergoing treatment for periodontal disease
    Alireza Shamaei-Tousi
    Division of Microbial Diseases, UCL Eastman Dental Institute, University College London, London, United Kingdom
    PLoS ONE 2:e1198. 2007
    ..We have used periodontitis and its treatment as a model of inflammation in the human to determine its effects on levels of circulating HSP10, HSP60 and BiP...
  9. ncbi Comparison of the sterilising activities of the nitroimidazopyran PA-824 and moxifloxacin against persisting Mycobacterium tuberculosis
    Y Hu
    Medical Microbiology, Department of Cellular and Molecular Medicine, St George s Hospital, University of London, London, United Kingdom
    Int J Tuberc Lung Dis 12:69-73. 2008
    ....
  10. ncbi Caught with their PAMPs down? The extracellular signalling actions of molecular chaperones are not due to microbial contaminants
    Brian Henderson
    UCL Eastman Dental Institute, University College London, UK
    Cell Stress Chaperones 15:123-41. 2010
    ..They show that sufficient evidence exists to support fully the hypothesis that molecular chaperones have cell-cell signalling actions that are likely to be part of the homeostatic mechanism of the vertebrate...
  11. ncbi Transposon mutagenesis identifies genes which control antimicrobial drug tolerance in stationary-phase Escherichia coli
    Yanmin Hu
    Department of Medical Microbiology, St George s Hospital Medical School, London SW17 ORE, UK
    FEMS Microbiol Lett 243:117-24. 2005
    ..coli. Furthermore, they show that it is important in murine infection during antibiotic treatment and lead to a faster kill of the mutant bacteria...